1. Method for the production of a formulation that is stable to oxidation and that is based on paracetamol in an aqueous solvent, comprising the steps of:
(i) dissolving paracetamol in an aqueous solvent comprising an isotonic agent that is sodium chloride and a buffer agent that is sodium citrate, having a temperature between 65\xb0 C. and 95\xb0 C. and having pH between 5.0 and 6.0 in a reaction vessel,
(ii) replacing the remaining air in the vessel by an inert gas, such as nitrogen, and cooling the solution so formed to a temperature below 38\xb0 C.,
(iii) adding cysteine hydrochloride to the solution without mechanical agitation, and
(iv) closing the reaction vessel and mechanically agitating the solution in a nitrogen atmosphere.
2. Method according to claim 1, wherein the aqueous solvent andor solution is not purged with an inert gas.
3. Method according to claim 2, wherein the inert gas is nitrogen.
4. Method according to claim 1, wherein the aqueous solvent has a temperature between 70\xb0 C. and 90\xb0 C. and preferably between 80\xb0 C. and 85\xb0 C.
5. Method according to claim 1, wherein the aqueous solvent has a pH between 5.6 and 5.7, and preferably of 5.5.
6. Method according to claim 1, wherein the paracetamol is present in the final solution in an amount of between 0.25% and 2% (wv).
7. Method according to claim 1, wherein the sodium chloride is present in the final solution in an amount of between 0.5% and 0.9% (wv).
8. Method according to claim 1, wherein the sodium citrate is present in the final solution in an amount of between 0.05% and 0.09% (wv).
9. Method according to claim 1, wherein the sodium citrate is monosodium citrate that is anhydrous, monohydrate, dihydrate or trihydrate.
10. Method according to claim 1, wherein the cysteine hydrochloride is the monohydrate form, and is present in the final solution in an amount between 0.015% and 0.035%.
11. Method according to claim 1, wherein the paracetamol is added to the aqueous solvent in step (i) without mechanical agitation.
12. Method according to claim 1, wherein the solution is stirred after replacing the remaining air in the vessel by the inert gas such as nitrogen in step (ii).
13. Method according to claim 1, wherein the solution in step (iv) is subsequently filtered prior to packaging in one or more vials.
14. Method according to claim 13, wherein the vials are closed under vacuum.
15. Formulation that is stable to oxidation and that is based on paracetamol in an aqueous solvent comprising:
between 0.25% and 2% (wv) paracetamol,
between 0.5% and 0.9% (wv) sodium chloride,
between 0.05% and 0.09% (wv) monosodium citrate monohydrate,
between 0.015% and 0.035% (wv) cysteine hydrochloride monohydrate, and
water for injection,
where the final pH of the formulation is between 5.0 and 6.0.
16. Formulation according to claim 15, wherein the water for injection is not degassed by bubbling with an inert gas.
17. Formulation according to claim 15, prepared according to a method comprising the steps of:
(i) dissolving paracetamol in an aqueous solvent comprising an isotonic agent that is sodium chloride and a buffer agent that is sodium citrate, having a temperature between 65\xb0 C. and 95\xb0 C. and having pH between 5.0 and 6.0 in a reaction vessel,
(ii) replacing the remaining air in the vessel by an inert gas, such as nitrogen, and cooling the solution so formed to a temperature below 38\xb0 C.,
(iii) adding cysteine hydrochloride to the solution without mechanical agitation, and
(iv) closing the reaction vessel and mechanically agitating the solution in a nitrogen atmosphere.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. Row of seats of a vehicle, comprising:
a) two outside seats;
b) an arm rest arranged between the two outside seats, the armrest having a free end and being foldable into a position corresponding to a back rest of adjacent outside seats in order to create the back rest for an emergency seat;
c) the emergency seat including a head rest with a retaining part arranged substantially above a top of the back rest, and into which support rods of the head rest are inserted, and the head rest including a contact part that extends forwardly and downwardly from the retaining part;
d) the back rest of the emergency seat being lockable in its state of use;
e) the head rest being height-adjustably guided in a frame from a retracted position to an extended position, the frame extending laterally into the region of the arm rest and is part of at least one of the adjacent seats; and
f) in the retracted position of the head rest, the contact part of the head rest overlapping the free end of the upwardly foldable arm rest in its upwardly folded position, in use.
2. Row of seats as claimed in claim 1, wherein:
a) the arm rest includes a recess at its free end for the complementary receiving of a bottom area of the contact part of the head rest when in a locked state.
3. Row of seats as claimed in claim 2, wherein:
a) a back wall of the frame includes a cutout in a region of the arm rest that is closed by the arm rest when the arm rest is in its upwardly folded position; and
b) the back wall serves as a back-to-front load opening for lengthy items from a luggage compartment when arm rest is in its downwardly folded position, in use.
4. Row of seats as claimed in claim 1, wherein:
a) a back wall of the frame includes a cutout in a region of the arm rest that is closed by the arm rest when the arm rest is in its upwardly folded position; and
b) the back wall serves as a back-to-front load opening for lengthy items from a luggage compartment when the arm rest is in its downwardly folded position, in use.